RVNC - Revance Therapeutics Inc. (RVNC) CEO Mark Foley on Q3 2019 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC)
Q3 2019 Earnings Conference Call
November 4, 2019 16:30 ET
Company Participants
Jeanie Herbert - Senior Director of IR & Corporate Communications
Mark Foley - President & CEO
Tobin Schilke - CFO & Principal Accounting Officer
Abhay Joshi - COO
Dustin Sjuts - Head of Commercial, Aesthetics & Therapeutics
Conference Call Participants
Annabel Samimy - Stifel
David Amsellem - Piper Jaffray
Jacob Hughes - Wells Fargo
Stacy Ku - Cowen & Company
Douglas Tsao - H.C. Wainwright
Tim Lugo - William Blair
Difei Yang - Mizuho Securities
Serge Belanger - Needham